US Patent Issued to Fresenius Medical Care Holdings on April 7 for "Techniques for modelling and optimizing dialysis toxin displacer compounds" (New Jersey, New York Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,597,482, issued on April 7, was assigned to Fresenius Medical Care Holdings Inc. (Waltham, Mass.).

"Techniques for modelling and optimizing dialysis toxin displacer compounds" was invented by Xia Tao (West New York, N.J.), Vaibhav Maheshwari (Jersey City, N.J.), Peter Kotanko (New York), Stephan Thijssen (New York) and Nadja Grobe (Huntington, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems, methods, and/or apparatuses may be operative to perform a dialysis process that includes a displacer infusion process. In one embodiment, a method for determining a displacer compound may include constructing a plurality of target protein quantitative st...